Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 21 Issue 1, January 2020

DAMPs' reprogramming of macrophage metabolism

Oxidized host-derived phospholipids such as oxPAPC can play important roles in atherosclerosis. Zanoni and colleagues demonstrate that oxPAPC potentiates the mitochondrial activity of macrophages and generates a distinctive metabolic and hyperinflammatory profile that can drive atherosclerosis in mice.

See Zanoni et al.

Image: Marco Di Gioia. Cover Design: Erin Dewalt.

Comment

  • Progress in understanding the rare disease Langerhans cell histiocytosis has stimulated immersive meetings occurring annually over a 30-year period that bring together clinicians, scientists and patients in a unique collaboration.

    • Carl E. Allen
    • Peter C. L. Beverley
    • Astrid van Halteren
    Comment

    Advertisement

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • NLRP3-driven sterile inflammation facilitates the pathogenesis of various human inflammatory diseases. New work identifies apolipoprotein C3 as an endogenous NLRP3 agonist that promotes sterile inflammation and organ damage.

    • Tao Gong
    • Rongbin Zhou
    News & Views
  • IL-33 is shown to play a cell-intrinsic role in maintenance of the functional identity of regulatory T cells in the tumor microenvironment. Genetic inhibition of IL-33 potentiates the therapeutic effect of checkpoint inhibitor immunotherapy in a melanoma mouse tumor model.

    • Annelies Demeyer
    • Rudi Beyaert
    News & Views
  • Hypoxia and acidity in the tumor microenvironment promote resistance to immunotherapy. Hypoxia upregulates multiple immunoinhibitory pathways, including VISTA, and acidity enables VISTA to interact with PSGL-1 to inhibit immune activation selectively in the acidic tumor microenvironment.

    • Kathleen M. Mahoney
    • Gordon J. Freeman
    News & Views
Top of page ⤴

Review Articles

Top of page ⤴

Articles

Top of page ⤴

Resources

  • The International Mouse Phenotyping Consortium (IMPC) aims to identify the function of all protein-coding genes in the mouse genome. Hayday and colleagues leverage 530 knockout lines from the IPMC to develop the 3i Project, which immunophenotypes mice and leads to the identification of new and unexpected gene influences on immune function and on the structural organization of the immune system.

    • Lucie Abeler-Dörner
    • Adam G. Laing
    • Adrian C. Hayday
    Resource
Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links